Clarithromycin-Based Standard Triple Therapy Can Still Be Effective forHelicobacter pyloriEradication in Some Parts of the Korea
Open Access
- 1 January 2014
- journal article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 29 (9) , 1240-1246
Abstract
Yoon KH, et al. J Korean Med Sci. 2014 Sep;29(9):1240-1246. http://dx.doi.org/10.3346/jkms.2014.29.9.1240Keywords
This publication has 28 references indexed in Scilit:
- Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus ReportGut, 2012
- Regional Difference of Antibiotic Resistance ofHelicobacter pyloriStrains in KoreaThe Korean Journal of Gastroenterology, 2011
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patientsJournal of Antimicrobial Chemotherapy, 2005
- Distribution of Antibiotic MICs for Helicobacter pylori Strains over a 16-Year Period in Patients from Seoul, South KoreaAntimicrobial Agents and Chemotherapy, 2004
- T2182C Mutation in 23S rRNA Is Associated with Clarithromycin Resistance in Helicobacter pylori Isolates Obtained in BangladeshAntimicrobial Agents and Chemotherapy, 2004
- H pylori antibiotic resistance: prevalence, importance, and advances in testingGut, 2004
- New Site of Modification of 23S rRNA Associated with Clarithromycin Resistance of Helicobacter pylori Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2002
- Antibiotic Resistance of Helicobacter pylori Strains in Japanese ChildrenJournal of Clinical Microbiology, 2002
- Helicobacter pylori in Peptic Ulcer DiseaseJAMA, 1994